Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria

Details for Australian Patent Application No. 2008290737 (hide)

Owner Nestec S.A.

Inventors Philippe, David; Mace, Catherine; Chou, Chieh Jason; Arigoni, Fabrizio; Darimont, Christian

Agent Shelston IP

Pub. Number AU-A-2008290737

PCT Pub. Number WO2009/024429

Priority 07114530.4 17.08.07 EP

Filing date 25 July 2008

Wipo publication date 26 February 2009

International Classifications

A61K 31/702 (2006.01) - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 36/00 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

18 March 2010 PCT application entered the National Phase

  PCT publication WO2009/024429 Priority application(s): WO2009/024429

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008290746-Process and hot-dip coating system for stabilizing a strip guided between stripping dies of the hot-dip coating system and provided with a coating

2008290647-1,4-diaza-bicyclo(3.2.2)nonyl pyrimidinyl derivatives useful as nicotinic acetylcholinereceptor ligands